At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials ending with over 10,000 participants, the company is waiting for approval.

HYDERABAD (Reuters) - Vaccine manufacturer Indian Immunologicals Limited (IIL) expects to commercially launch its dengue fever vaccine by early 2026, a top executive said, as the race to develop the ...

NEW DELHI (AP) — The World Health Organization granted an emergency use license Nov. 3 to a coronavirus vaccine developed in India, offering reassurance for a shot the country’s regulators allowed ...

The US will no longer recommend some childhood vaccines for all children, leaving the decision to families and doctors. Will this decision affect India? Here's what experts decode.

A trio of new vaccines could provide a lifeline in the fight against cholera at a time when cases are soaring worldwide, ...